- Home
- NTLA vs PENG Comparison
NTLA vs PENG Comparison
Compare NTLA & PENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTLA
- PENG
- Stock Information
- Founded
- NTLA 2014
- PENG 1988
- Country
- NTLA United States
- PENG Cayman Islands
- Employees
- NTLA N/A
- PENG N/A
- Industry
- NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- PENG Semiconductors
- Sector
- NTLA Health Care
- PENG Technology
- Exchange
- NTLA Nasdaq
- PENG Nasdaq
- Market Cap
- NTLA 1.0B
- PENG 1.1B
- IPO Year
- NTLA 2016
- PENG 2017
- Fundamental
- Price
- NTLA $9.62
- PENG $16.67
- Analyst Decision
- NTLA Buy
- PENG Strong Buy
- Analyst Count
- NTLA 18
- PENG 7
- Target Price
- NTLA $39.44
- PENG $25.43
- AVG Volume (30 Days)
- NTLA 3.8M
- PENG 653.6K
- Earning Date
- NTLA 05-08-2025
- PENG 04-08-2025
- Dividend Yield
- NTLA N/A
- PENG N/A
- EPS Growth
- NTLA N/A
- PENG N/A
- EPS
- NTLA N/A
- PENG N/A
- Revenue
- NTLA $57,877,000.00
- PENG $1,237,651,000.00
- Revenue This Year
- NTLA N/A
- PENG $18.38
- Revenue Next Year
- NTLA N/A
- PENG $10.03
- P/E Ratio
- NTLA N/A
- PENG N/A
- Revenue Growth
- NTLA 59.55
- PENG N/A
- 52 Week Low
- NTLA $8.30
- PENG $14.87
- 52 Week High
- NTLA $28.88
- PENG $29.81
- Technical
- Relative Strength Index (RSI)
- NTLA 44.22
- PENG N/A
- Support Level
- NTLA $8.64
- PENG N/A
- Resistance Level
- NTLA $10.68
- PENG N/A
- Average True Range (ATR)
- NTLA 0.91
- PENG 0.00
- MACD
- NTLA -0.09
- PENG 0.00
- Stochastic Oscillator
- NTLA 30.48
- PENG 0.00
About NTLA Intellia Therapeutics Inc.
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.
About PENG Penguin Solutions Inc. Ordinary Shares
Penguin Solutions Inc is an end-to-end technology company engaged in Intelligent Platform Solutions, Integrated Memory, and Optimized LED business. Its product include Servers, software, OCP HPC & AI system, Racks and Edge. Servers include AMD-based Serves, Intel-based Servers, etc. Software products include Scyld ClusterWare, Scyld Cloud Central, etc. OCP HPC & AI Systems includes OCP Servers & Storage and etc.